Antares Pharma, Inc. (ATRS)

Operating Cash Flow (Statement)

$29.76M

TTM · Period ending: · USD

ATRS logo

ATRS Operating Cash Flow (Statement)

Latest reported$29.76M
ATRS TTM Cash from Operations (-$3.12M → $29.76M)
High-resolution chart · PNG

ATRS operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
29,760,000
36,619,000
34,230,000
20,470,000
17,718,000
21,320,000
13,087,000
9,828,000
6,955,000
-10,615,000
-16,647,000
-18,422,000
-23,283,000
-17,322,000
-17,771,731
-23,081,559
-25,141,354
-23,094,000
-18,980,978
-16,606,257
-15,212,782
-15,194,942
-14,044,479
-17,018,909
-21,504,414
-28,198,841
-31,706,285
-33,057,434
-30,030,646
-26,333,301
-22,151,735
-19,407,037
-17,885,896
-14,968,151
-15,790,154
-13,069,458
-13,000,075
-10,472,988
-5,565,611
-4,971,000
-1,734,757
-1,926,007
-5,090,828
-5,316,039
-5,403,477
-6,079,370
-7,410,350
-4,166,933
-5,229,620
-5,099,560
-5,208,115
-9,920,625
-10,316,130
-10,324,412
-9,527,869
-8,181,323
-7,750,837
-5,394,276
-4,493,025
-4,252,479
-3,111,676
-6,118,050
-6,587,881
-6,685,571
-7,487,876
-7,218,529
-8,252,967
-8,783,323
-8,321,932
-7,167,313
-5,330,732
-5,220,897
-4,830,443
-3,553,322
-4,291,836
-3,702,667
-3,833,271
-5,553,766
-1,408,444
-1,319,304
-2,228,295
-2,654,480
-6,970,943
-6,566,312
-5,574,807
-3,732,123
-3,392,958
-3,471,794
-3,047,633
-2,633,490
-4,011,881
-4,311,881
-4,811,881
-5,011,881
-3,821,669
-3,421,669
-2,721,669
-3,121,669
-3,542,311
-3,042,311
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.